0
0
On September 3, 2025, the Goods and Services Tax (GST) Council of India announced a historic decision to exempt all individual health and term life insurance premiums from the 18% GST levy, effective from September 22, 2025. The announcement, made by Union Finance Minister Nirmala Sitharaman after the 56th GST Council meeting in New Delhi, aims to make insurance products more affordable for millions of Indians and expand insurance coverage across the country. This landmark exemption applies to all individual health insurance policies—including family floater plans and senior citizen plans—as well as individual life insurance policies such as term life, ULIPs, and endowment plans along with their reinsurance services.
Key Developments and Intended Impact
The GST Council’s decision to bring health and life insurance premiums under the NIL GST bracket represents a significant fiscal reform designed to ease the immediate financial burden on policyholders. Currently, insurance premiums attract an 18% GST, which adds substantially to the cost of policies. For example, a policyholder paying an annual premium of ₹20,000 could have paid an additional ₹3,600 as GST, bringing the total cost to ₹23,600. With the GST exemption, customers will pay only the base premium quoted by insurers, potentially reducing the effective cost of these policies by approximately 15% or more.
Dr. Tapan Singhel, Managing Director and CEO of Bajaj Allianz General Insurance, praised the move as “a landmark decision” that will make health protection more affordable amidst rising medical inflation. He noted that the exemption aligns with the government’s broader vision of “Insurance for All by 2047,” emphasizing how it can accelerate insurance penetration and strengthen the nation’s health security.
Hanut Mehta, CEO and Co-Founder of BimaPay Finsure, highlighted that the reduction in upfront costs could encourage a larger base of first-time buyers and lead to wider adoption of premium financing options. He also suggested that the price relief might encourage policyholders to consider higher sum insured amounts, improving overall health security.
Background and Context: GST on Health Insurance in India
Before this development, health and life insurance products were subject to an 18% GST levy under the Harmonized System of Nomenclature (HSN) code 997133. This tax significantly contributed to higher premiums, which deterred many middle-income families and senior citizens from purchasing insurance, especially in a country where insurance penetration remains low compared to global standards. The increase in premium costs due to GST was viewed as a barrier to insurance adoption, limiting financial protection against escalating healthcare costs.
The decision to exempt these insurance premiums comes after several recommendations and reports by the Group of Ministers (GoM) and the GST Council to address these affordability challenges. By bringing premiums under the NIL GST bracket, the government reinforces the perspective that health and life insurance are essential, not luxury, products demanding accessible pricing for the broader population.
Expert Perspectives and Industry Insights
While industry leaders have welcomed the GST exemption, some experts caution that the impact on premiums might be nuanced. Insurance companies currently benefit from input tax credits (ITC) on various operational inputs, which help moderate costs. With the GST exemption, insurers might lose these ITC benefits, potentially leading to some operational cost increases. Consequently, over time, some of these costs could be incorporated into the base premiums, partly offsetting the anticipated savings for policyholders. The Insurance Regulatory and Development Authority of India (IRDAI) is expected to provide detailed guidelines soon to clarify the treatment of ITC under the new exemption framework.
Despite this, the consensus remains that the overall effect will be positive for consumers, particularly the growing middle class and underserved populations, by making health and life insurance coverage more financially accessible. Experts emphasize the need for clear regulatory guidelines to ensure insurers pass the benefits to customers transparently and promptly.
Public Health and Practical Implications
With increasing medical inflation and rising health risks, affordable insurance coverage is critical for financial protection. This tax exemption could incentivize more individuals and families to invest in health and life insurance policies, providing a safety net against unexpected medical costs and enhancing overall health security.
For the public, the immediate practical implication is a reduced premium outlay, which can ease monthly or annual budget constraints and potentially allow consumers to opt for more comprehensive insurance plans. This move is expected to boost insurance penetration rates in India, which is a crucial step toward achieving universal health coverage and protecting more citizens from catastrophic health expenditures.
Limitations and Considerations
The GST exemption is a progressive step, but its full benefits depend on effective implementation, including ensuring that insurers adjust pricing models to reflect the tax relief without hidden costs. Policymakers must monitor the market response and ensure transparent communication to consumers about new premium rates.
Additionally, while the exemption applies to individual health and life insurance, policies provided by employers or government-sponsored schemes might have different GST treatments, which consumers should verify. Moreover, the long-term impact on insurer revenues and the broader insurance ecosystem needs careful evaluation to maintain market stability.
Medical Disclaimer
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
References
